Correction to: Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3 (Cancer Gene Therapy, (2014), 21, 7, (290-296), 10.1038/cgt.2014.29)

R. Gan, Y. Yang, X. Yang, L. Zhao, J. Lu, Q. H. Meng

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to: Cancer Gene Ther, published online 13 June 2014 Following the publication of this article, the authors noted that the panel in Figure 1b for AS-miR-221 had mistakenly been placed to show AS-miR-221/222. The correct panel for AS-miR-221/222 has now been included in the below revised figure. The conclusions of the article are unaffected by this correction. (Figure presented.) The original article has been corrected.

Original languageEnglish (US)
Pages (from-to)1582
Number of pages1
JournalCancer gene therapy
Volume30
Issue number11
DOIs
StatePublished - Nov 2023

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3 (Cancer Gene Therapy, (2014), 21, 7, (290-296), 10.1038/cgt.2014.29)'. Together they form a unique fingerprint.

Cite this